Previous findings suggest a link between the copper transport protein ATOX1 and NADPH oxidase in inflammatory neovascularization, indicating that ATOX1 is a potential therapeutic target for the treatment of ischemic disease (Chen et al., 2015). Here, FMO5 is linked to ischemic disease.